🎁 Black Friday: up to 50% off of annual plans

James Condulis

Stock Analyst at Stifel Nicolaus

(0.49)
# 4,452
Out of 5,189 analysts
75
Total ratings
30.6%
Success rate
-7%
Average return

Stocks Rated by James Condulis

Aardvark Therapeutics
Nov 19, 2026
Maintained: Hold
Price Target: $6 → $2
Current: $0.9226
Upside: +116.78%
Arrowhead Pharmaceuticals
Nov 13, 2026
Reiterated: Buy
Price Target: $104 → $96
Current: $41.37
Upside: +132.05%
Braveheart Bio
Nov 9, 2026
Reiterated: Buy
Price Target: $45
Current: $20.39
Upside: +120.70%
NewAmsterdam Pharma Company
Nov 9, 2026
Reiterated: Buy
Price Target: $50
Current: $18.41
Upside: +171.59%
Tectonic Therapeutic
Nov 6, 2026
Reiterated: Buy
Price Target: $75
Current: $20.73
Upside: +261.79%
Cytokinetics
Nov 5, 2026
Reiterated: Buy
Price Target: $108
Current: $50.78
Upside: +112.68%
Edgewise Therapeutics
Nov 5, 2026
Reiterated: Hold
Price Target: $36
Current: $39.91
Upside: -9.79%
X4 Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $10
Current: $3.00
Upside: +233.33%
Mirum Pharmaceuticals
Nov 4, 2026
Reiterated: Buy
Price Target: $156
Current: $96.13
Upside: +62.28%
Amylyx Pharmaceuticals
Oct 1, 2026
Reiterated: Buy
Price Target: $45
Current: $26.02
Upside: +72.94%
Initiated Coverage: Buy
Price Target: $18
Current: $5.56
Upside: +223.74%
Rated: Hold
Price Target: n/a
Current: $3.69
Upside: -